Skip to content

Talphera, Inc. TLPH Current Debt

Discontinued — last reported Q4 '23

Current Debt at other companies

Baxter International logo
Baxter InternationalBAX
$0-100%
AMP
Amphastar PharmaceuticalsAMPH
$1.67M+646%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$350M+4.2%
Royalty Pharma logo
Royalty PharmaRPRX
$380M-61.9%
XOMA Corporation logo
XOMA CorporationXOMA
$14.01M+2.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$22.5M

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Talphera, Inc.’s 10-K, filed March 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s current debt?
Talphera, Inc. (TLPH) reported current debt of $0 in Q4 2023.
How has Talphera, Inc.'s current debt changed year-over-year?
Talphera, Inc.'s current debt decreased by 100.0% year-over-year, from $5.36M to $0.
What is the long-term trend for Talphera, Inc.'s current debt?
Over 3 years (2020 to 2023), Talphera, Inc.'s current debt has grown at a -100.0% compound annual growth rate (CAGR), from $8.74M to $0.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.